Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
Date:2/14/2008

justment 574,966 106,623 391,115 62,937

COMPREHENSIVE INCOME $3,747,293 $2,028,476 $2,043,486 $1,049,254

STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED DECEMBER 31,

(UNAUDITED)

2007 2006

CASH FLOWS FROM OPERATING ACTIVITIES

Net Income $3,172,327 $1,921,853

Adjustments to reconcile net income to net

cash

provided by operating activities:

Depreciation and amortization 164,758 221,171

Bad debt expense -- 19,308

Changes in current assets and current

liabilities:

Accounts receivable

(6,899) (1,392,038)

Inventory 306,194 (400,339)

Advance payments to vendors (1,040,484) 462,864

Other receivables

(624,610) 22,354

Accounts payable and accrued

expenses (252,002) 355,753

VAT taxes payable

(16,051) 19,584

Income tax payable

(20,953) (683)

Payroll taxes payable

(1,707) (13,584)

Other payables

66,426 (174,200)

Total Adjustments (1,425,328) (879,810)

Net Cash Provided by Operating

Activities
'/>"/>

SOURCE Tianyin Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
...-Madison faculty members Sean Carroll and Laura K...National Academy of Sciences . , ,Election to the ...honors bestowed upon American scientists. Carroll,...d Kiessling, a professor of chemistry and biochemi...ts and ongoing contributions to original research....
...y , the California biotechnology company that anno... stem cells from human embryos without destroying ...tion agreement with the Wisconsin Alumni Research...the right to the commercial use of human embryonic...,Advanced Cell Technology, based in Alameda, Calif...
...uebsch , R-West Salem, and State Rep. Phil Montgo...o serve on the Speaker,s Task Force on Information... is charged with exploring a number of failed info...nd learning from successful projects in the public..., who will serve as chair of the task force, the p...
Other Biology Technology:WARF expands license agreement with Advanced Cell Technology 2Eight lawmakers named to Speaker's IT task force 2
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2U-Iowa study helps advance heart-related research 2Papillomavirus silences innate immune response 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 1Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 4Chromosomal problems affect nearly all human embryos 9081 1Chromosomal problems affect nearly all human embryos 9081 2Chromosomal problems affect nearly all human embryos 9081 3Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 1Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 2Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 3
...nologies have largely failed to deliver the hoped-...es of disease-causing bacteria, says a leading Can...niques such as genomic sequencing and high through...t of new antibiotic compounds easier and more prod... hold the upper hand ?and if three billion years o...
...of Biology of Reproduction contains a report of so... when nuclei from one genus of fish were transplan..., The seven offspring, cloned from nuclei of commo...ly identical to the nuclear donor species, Cyprinu...s. The number of vertebrae in the clones, however,...
... microscaled worms ( C. Elegans ),is quite a chall...om,the University of Texas at Austin developed a m...ittle beasts, being able to section a single,axon ...n,ultra-short pulse laser that can perform extreme...ey to understanding nerve regeneration and,is an i...
Other Biology News:Learning to fight an adversary that won't stay down 2“Nano-scissors?laser shows precise surgical capability 2
Mouse Anti-nicotinic Acetylcholine Receptor Monoclonal Antibody, Unconjugated, Clone 88B from Abcam
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Mouse Anti-Secretory Component Glycoprotein Monoclonal Antibody, Unconjugated, Clone SPM217 from Abcam
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: